+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GUJTHEM

Gujarat Themis Biosyn Share Price

₹324.00 -29.4 (-8.32%)
32.36% Fall from 52W High

23 Oct, 2026 3:54 PM (IST)

Gujarat Themis Biosyn live price: ₹324.00. It opened at ₹349 vs previous close ₹353; intraday high/low: ₹354/₹314. The 50 & 200 DMA stand at ₹384.00/₹370.40.

Gujarat Themis Biosyn Performance

  • Today's Low
  • ₹314
  • Today's High
  • ₹354
  • 52 Week Low
  • ₹225
  • 52 Week High
  • ₹479
  • Open Price₹349
  • Previous Close₹353
  • Volume974,224
  • 50 DMA₹384.00
  • 100 DMA₹380.80
  • 200 DMA₹370.40

Gujarat Themis Biosyn Chart

Investment Returns

  • Over 1 Month -21.12%
  • Over 3 Month -9.07%
  • Over 6 Month -0.13%
  • Over 1 Year -28.37%

Smart Investing Starts Here Start SIP with Gujarat Themis Biosyn for Steady Growth!

Invest Now

Gujarat Themis Biosyn Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 86.6
  • PEG Ratio
  • 9.4
  • Market Cap Cr
  • 4,217
  • P/B Ratio
  • 14
  • Average True Range
  • 21.2
  • EPS
  • 3.7
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -14.8
  • RSI
  • 30.62
  • MFI
  • 34.51

Latest Stock News Updates

Gujarat Themis Biosyn Ltd - 506879 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Kindly refer to the RTA compliance Certificate for the quarter ended 30.09.2026.

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Please refer to our Scrutinizer Report and Voting Results of 45th Annual General Meeting counter signed by the Chairman.

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Please refer to our counter signed Scrutinizer''s Report of 45th Annual General Meeting.

Gujarat Themis Biosyn Financials

Gujarat Themis Biosyn Technicals

EMA & SMA

Current Price
₹324.00
-29.4 (-8.32%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹373.10
  • 50 Day
  • ₹384.00
  • 100 Day
  • ₹380.80
  • 200 Day
  • ₹370.40

Resistance and Support

330.67 Pivot Speed
  • R3 387.20
  • R2 370.60
  • R1 347.30
  • S1 307.40
  • S2 290.80
  • S3 267.50

Gujarat Themis Biosyn Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-10 Others
2026-09-01 Preferential issue of shares
2026-08-07 Quarterly Results
2026-06-19 To consider Fund Raising (Cancelled )
2026-06-06 Fund Raising & Others To consider other business matters.
Date Purpose Remarks
2026-09-23 FINAL Rs.0.67 per share(67%)Final Dividend
2025-09-05 FINAL Rs.0.67 per share(67%)Final Dividend
2024-02-22 INTERIM Rs.0.75 per share(75%)Interim Dividend
2022-12-02 INTERIM Rs.4.40 per share(88%)Interim Dividend
2021-11-25 INTERIM Rs.2.00 per share(40%)Interim Dividend
View Gujarat Themis Biosyn Dividend History Arrow
Date Purpose Remarks
2023-10-10 Split Stock split from Rs. 5/- to Re. 1/-.
Date Purpose Remarks
2024-08-09 Bonus Bonus issue in the ratio of 1:2 of Re. 1/-.

Gujarat Themis Biosyn Shareholding Pattern

59.33%
24.21%
9.63%
3.8%
3.02%

About Gujarat Themis Biosyn

Gujarat Themis Biosyn is principally engaged in the activities pertaining to manufacturing of Bulk Drugs. View More
  • NSE Symbol
  • GUJTHEM
  • BSE Symbol
  • 506879
  • ISIN
  • INE942C01045

Similar Stocks to Gujarat Themis Biosyn

Gujarat Themis Biosyn FAQs

Gujarat Themis Biosyn share price is ₹324 As on 24 October, 2026 | 23:36

The Market Cap of Gujarat Themis Biosyn is ₹4216.9 Cr As on 24 October, 2026 | 23:36

The P/E ratio of Gujarat Themis Biosyn is 86.6 As on 24 October, 2026 | 23:36

The PB ratio of Gujarat Themis Biosyn is 14 As on 24 October, 2026 | 23:36

The 52 week High & Low of Gujarat Themis Biosyn is ₹479/₹225 respectively As on 24 October, 2026 | 23:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23